JPWO2021200800A1 - - Google Patents

Info

Publication number
JPWO2021200800A1
JPWO2021200800A1 JP2022512195A JP2022512195A JPWO2021200800A1 JP WO2021200800 A1 JPWO2021200800 A1 JP WO2021200800A1 JP 2022512195 A JP2022512195 A JP 2022512195A JP 2022512195 A JP2022512195 A JP 2022512195A JP WO2021200800 A1 JPWO2021200800 A1 JP WO2021200800A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022512195A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021200800A1 publication Critical patent/JPWO2021200800A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/165—Coronaviridae, e.g. avian infectious bronchitis virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
JP2022512195A 2020-03-30 2021-03-29 Pending JPWO2021200800A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020061369 2020-03-30
PCT/JP2021/013237 WO2021200800A1 (en) 2020-03-30 2021-03-29 Vaccine for preventing or treating coronavirus infection or symptoms associated with coronavirus infection

Publications (1)

Publication Number Publication Date
JPWO2021200800A1 true JPWO2021200800A1 (en) 2021-10-07

Family

ID=77929420

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022512195A Pending JPWO2021200800A1 (en) 2020-03-30 2021-03-29

Country Status (3)

Country Link
JP (1) JPWO2021200800A1 (en)
TW (1) TW202144574A (en)
WO (1) WO2021200800A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021213924A1 (en) 2020-04-22 2021-10-28 BioNTech SE Coronavirus vaccine
WO2024002985A1 (en) 2022-06-26 2024-01-04 BioNTech SE Coronavirus vaccine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006009011A1 (en) * 2004-07-15 2006-01-26 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Coronaviral spike s1 fused protein and expression vector therefor
JP4665122B2 (en) * 2004-10-08 2011-04-06 財団法人 東京都医学研究機構 Recombinant virus and its use
GB0822001D0 (en) * 2008-12-02 2009-01-07 Glaxosmithkline Biolog Sa Vaccine

Also Published As

Publication number Publication date
TW202144574A (en) 2021-12-01
WO2021200800A1 (en) 2021-10-07

Similar Documents

Publication Publication Date Title
BR112023005462A2 (en)
BR112021014123A2 (en)
JPWO2021200800A1 (en)
BR112022024743A2 (en)
BR102021018859A2 (en)
BR112022009896A2 (en)
BR102021007058A2 (en)
BR112023004146A2 (en)
BR112023006729A2 (en)
BR102021020147A2 (en)
BR102021018926A2 (en)
BR102021018167A2 (en)
BR102021017576A2 (en)
BR102021016837A2 (en)
BR102021016551A2 (en)
BR102021016375A2 (en)
BR102021016176A2 (en)
BR102021016200A2 (en)
BR102021015566A2 (en)
BR102021015500A2 (en)
BR102021015450A8 (en)
BR102021015220A2 (en)
BR102021015247A2 (en)
BR102021014044A2 (en)
BR102021014056A2 (en)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240313